Research Gallery

Subscribe to Research Gallery feed Research Gallery
Updated: 8 min 55 sec ago

Point-of-care testing cuts antibiotic use in COPD

Point-of-care C-reactive protein testing reduces antibiotic use in people with acute COPD exacerbations, a study published in The New England Journal of Medicine has shown.

Number of clinical pharmacists expected to work in PCNs rises to 7,500 by 2023/2024

The number of clinical pharmacists needed to work in the new primary care networks in England by 2023/2024 could be as high as 7,500, according to a calculation by London GPs.

MHRA 'assessing reports' of respiratory illness outbreak linked to e-cigarettes in the United States

The Medicines and Healthcare products Regulatory Agency is reviewing information about a respiratory illness that has been linked to e-cigarette use in the United States.

Government reforms of Category M reimbursement risk 'exacerbating' drug shortages, says PSNC

The government risks making drugs shortages worse with its generics reimbursement reforms, unless the proposals are rolled out gradually, the Pharmaceutical Services Negotiating Committee has said.

NHS Scotland to provide £100,000-per-year cystic fibrosis drug

A five-year deal to supply NHS Scotland with cystic fibrosis drugs Orkambi and Symkevi has been secured after discussions between the manufacturer, Vertex Pharmaceuticals, and the Scottish government.

Pass rate gap widens for black trainees in preregistration exam

The difference in pass rates between black African and white British preregistration trainees taking the General Pharmaceutical Council registration assessment has widened by four percentage points since 2018.

Binning the sharps: the quest for oral insulin

The pharmaceutical industry has been trying to develop oral formulations of insulin since the 1920s without success, but, over the past few years, several new oral delivery systems have shown promise in clinical trials.

Primary care networks should make use of independent prescribers in community pharmacy, says RPS

Primary care networks should make greater use of community pharmacy-based independent prescribers, the Royal Pharmaceutical Society has said.

Potential interaction between diuretics and laxatives found

Researchers have identified a plausible drug–drug interaction between laxatives and non-potassium-sparing diuretics.

Medicines face six months of delays at the border in 'worst-case' no-deal Brexit scenario

Medicine and medical product supply chains could experience “severe extended delays” for up to six months in the “worst case” scenario after the UK leaves the EU, according to a government report.

GPhC to further work on five-year integrated training as 76% of consultation responses show support

The General Pharmaceutical Council has said that it will “take forward work” on implementing five-year integrated education and training for pharmacy students after more than two-thirds of respondants to a consultation agreed with the proposal.

GPhC prescribing guidance may restrict some patients from accessing their medicines, consultation told

Guidance for pharmacist prescribers is “too restrictive” and could make it more difficult for patients to access the medicines they require, respondents to a General Pharmaceutical Council consultation have said.

Jersey government could temporarily close pharmacies in no-deal Brexit scenario

Pharmacies on Jersey could be temporarily closed if a no-deal Brexit leads to severe medicines shortages, under an amendment to emergency powers passed on 10 September 2019.

Majority of pharmacists need support managing stress at work, survey finds

More than 60% of pharmacists need support with stress at work, a survey carried out by the charity Pharmacist Support has revealed.

Public should avoid e-cigarettes during investigation of respiratory illness, US government advises

The public should “consider not using e-cigarette products” while investigations into the outbreak of a severe respiratory illness in e-cigarette users in the United States take place, the Centers for Disease Control and Prevention has recommended.

Novel migraine therapy relieves pain and bothersome symptoms

Rimegepant, a medicine belonging to a new class of migraine treatments, relieves pain and other symptoms in patients with moderate or severe migraine pain, research published in The New England Journal of Medicine has shown.

More than 500,000 patients in England were prescribed an opioid for over three years, PHE finds

A review published by Public Health England has found that more than 500,000 patients in England were continuously prescribed an opioid for three years or more, despite a lack of evidence showing their efficacy in the long term.

Five important features of the new community pharmacy contract

A summary of the main points of the new contract that community pharmacists in England need to know about before October 2019.

NHS BSA overturns more than 20,000 prescription penalty notices after patients are found to have already paid

The number of penalty notices issued for fraudulently claiming free prescriptions that have been overturned increased to more than 20,000 in 2018/2019 because these patients had paid for their prescriptions.

Boots to trial video GP consultations

Boots is to pilot an in-store video GP service that, it says, could increase patient access to healthcare services.